泛免疫炎症指数对老年冠心病患者PCI术后1年内主要心血管不良事件的预测价值

doi:10.13481/j.1671-587X.20250621

Abstract

Abstract:

Objective To discuss the clinical value of pan-immune inflammation index （PIV） in predicting the major adverse cardiovascular events （MACE） within 1 year after percutaneous coronary intervention （PCI） in the elderly patients with coronary heart disease， and to clarify the role of inflammatory response in postoperative recovery and prognosis of the patients with coronary heart disease. Methods A total of 150 elderly patients with coronary heart disease who underwent PCI from July 2020 to August 2023 were selected as the research subjects； according to the occurrence of MACE within 1 year after operation， they were divided into MACE group （n=28） and non-MACE group （n=122）； the baseline data and biochemical indicators of the patients were collected， and PIV was calculated； multivariate Logistic regression was used to analyze the influencing factors of MACE within 1 year after PCI in the elderly patients with coronary heart disease； receiver operating characteristic （ROC） curve was used to analyze the predictive value of PIV for MACE within 1 year after PCI in the elderly patients with coronary heart disease. Results Compared with non-MACE group， the levels of total cholesterol （TC） and low-density lipoprotein cholesterol （LDL-C）， neutrophils （NEUT）， platelets （PLT） counting and PIV in the patients in MACE group were significantly increased （P<0.05）； there were no significant differences in other data between two groups （P>0.05）. The multivariate Logistic regression analysis results showed that the levels of TC （OR=1.571， 95%CI： 1.088-2.270） and LDL-C （OR=32.506， 95%CI： 8.880-118.994） and PIV （OR=1.014， 95%CI： 1.010-1.019） were the influencing factors of MACE within 1 year after PCI in the elderly patients with coronary heart disease （P<0.05）. The ROC curve analysis results showed that the area under the ROC curve （AUC） of PIV for predicting MACE was 0.857 （95%CI： 0.762-0.951）， the sensitivity was 0.821， the specificity was 0.959， the maximum Youden index was 0.780， and the best cut-off value was 778.805 （P<0.01）. Conclusion PIV has important predictive value for MACE within 1 year after PCI in elderly patients with coronary heart disease.

Key words: Coronary heart disease, Pan-immune inflammation index, Major adverse cardiovascular events, Percutaneous coronary intervention, Elderly

CLC Number:

R541.4

Tao SUN,Zhiyin DAI,Xuan LI,Chaopu ZHANG,Shu DING,Jianwei ZHAO. Predictive value of pan-immune-inflammation index for major adverse cardiovascular events within 1 year after PCI in elderly patients with coronary heart disease[J].Journal of Jilin University(Medicine Edition), 2025, 51(6): 1655-1660.

Figures/Tables 3

References 19

[1]	DUGGAN J P， PETERS A S， TRACHIOTIS G D， et al. Epidemiology of coronary artery disease［J］. Surg Clin North Am， 2022， 102（3）： 499-516.
[2]	The Writing Committee of the Report on Cardiovascular Health and Diseases in China. 中国心血管健康与疾病报告2020概要［J］. 中国循环杂志， 2021， 36（6）： 521-545.
[3]	SIMANTIRIS S， PAPASTAMOS C， ANTONOPOULOS A S， et al. Oxidative stress biomarkers in coronary artery disease［J］. Curr Top Med Chem， 2023， 23（22）： 2158-2171.
[4]	ZHU X Y， YANG D D， ZHANG K J， et al. Comparative analysis of four nutritional scores predicting the incidence of MACE in older adults with acute coronary syndromes after PCI［J］. Sci Rep， 2023， 13（1）： 20333.
[5]	JENAB Y， HEDAYAT B， KARIMI A， et al. Effects of opium use on one-year major adverse cardiovascular events （MACE） in the patients with ST-segment elevation MI undergoing primary PCI： a propensity score matched-machine learning based study［J］. BMC Complement Med Ther， 2023， 23（1）： 16.
[6]	DOENST T， HAVERICH A， SERRUYS P， et al. PCI and CABG for treating stable coronary artery disease： JACC review topic of the week［J］. J Am Coll Cardiol， 2019， 73（8）： 964-976.
[7]	DOLAPOGLU A， AVCI E. Relationship between pan-immune- inflammation value and in major cardiovascular and cerebrovascular events in stable coronary artery disease patients undergoing on-pump coronary artery bypass graft surgery［J］. J Cardiothorac Surg， 2024， 19（1）： 241.
[8]	SAYLIK F， AKBULUT T. Systemic immune-inflammation index predicts major cardiovascular adverse events in patients with ST-segment elevated myocardial infarction［J］. Arq Bras Cardiol， 2022， 119（1）： 14-22.
[9]	ZHANG C Y， LI M H， LIU L， et al. Systemic immune-inflammation index as a novel predictor of major adverse cardiovascular events in patients undergoing percutaneous coronary intervention： a meta-analysis of cohort studies［J］. BMC Cardiovasc Disord， 2024， 24（1）： 189.
[10]	中华医学会，中华医学会杂志社，中华医学会全科医学分会，等. 稳定性冠心病基层诊疗指南（2020年）［J］. 中华全科医师杂志， 2021， 20（3）： 265-273.
[11]	YAMANOUCHI K， MAEDA S. The efficacy of inflammatory and immune markers for predicting the prognosis of patients with stage Ⅳ breast cancer［J］. Acta Med Okayama， 2023， 77（1）： 37-43.
[12]	SCHLEIGER A， KRAMER P， DREYSSE S， et al. Coronary interventions in pediatric congenital heart disease［J］. Pediatr Cardiol， 2022， 43（4）： 769-775.
[13]	LIU W Q， YANG W L， QIAN S Y. The mediating effect of self-efficacy on health literacy and social support in young and middle-aged patients with coronary heart disease after PCI［J］. Vasc Health Risk Manag， 2023， 19： 341-349.
[14]	SUGIHARTO F， NURAENI A， TRISYANI Y， et al. Barriers to participation in cardiac rehabilitation among patients with coronary heart disease after reperfusion therapy： a scoping review［J］. Vasc Health Risk Manag， 2023， 19： 557-570.
[15]	PIZZOLO F， CASTAGNA A， OLIVIERI O， et al. Basophil blood cell count is associated with enhanced factor Ⅱ plasma coagulant activity and increased risk of mortality in patients with stable coronary artery disease： not only neutrophils as prognostic marker in ischemic heart disease［J］. J Am Heart Assoc， 2021， 10（5）： e018243.
[16]	SREEJIT G， ABDEL LATIF A， MURPHY A J， et al. Emerging roles of neutrophil-borne S100A8/A9 in cardiovascular inflammation［J］. Pharmacol Res， 2020， 161： 105212.
[17]	OZILHAN M O， ÇAKMAK KARAASLAN O， ACIKGOZ S K， et al. Systemic inflammation response index is associated MACE in patients with NSTEMI［J］. Eur Rev Med Pharmacol Sci， 2023， 27（18）： 8588-8597.
[18]	张翥，祁建成，陶亮亮，等. 血清Lp-PLA2、血小板聚集率、平均血小板体积/血小板计数比值与老年冠心病患者主要不良心血管事件的相关性分析［J］. 海军医学杂志， 2023（12）： 1248-1253.
[19]	DREGOESC M I， IGU A B， BEKKERING S， et al. Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease［J］. Int J Cardiol， 2024， 400： 131780. T
	,

Group	n	Gender（Male/Female）	Age (year)（x±s）	BMI（kg·m^-2）（x±s）	Hypertension[n（η/%）]	Diabetes mellitus[n（η/%）]	High blood lipids[n（η/%）]
Non-MACE	122	97/25	73.11±1.15	24.73±2.11	76（62.30）	45（36.89）	21（17.21）
MACE	28	20/8	72.75±1.08	24.82±2.05	17（60.71）	9（32.14）	3（10.71）
t/χ²		0.866	1.510	0.205	0.024	0.222	0.716
P		0.352	0.133	0.838	0.876	0.637	0.398

Independent variable	B	SE	Wald χ²	P	OR	95%CI
TC	0.452	0.188	5.805	0.016	1.571	1.088-2.270
LDL	3.481	0.662	27.650	<0.001	32.506	8.880-118.994
PIV	0.014	0.002	46.217	<0.001	1.014	1.010-1.019

Predictive value of pan-immune-inflammation index for major adverse cardiovascular events within 1 year after PCI in elderly patients with coronary heart disease

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 19

Related Articles 15

Metrics

Comments

Recommended 10

[1]	Di QIN,Lihong HUAGN,Qingshuang ZHENG,Jingjing SUN,Weimin XU. Analysis on correlation between serum pro-inflammatory cytokines and muscle mass in elderly patients with sarcopenic obesity and diabetes [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1293-1302.
[2]	Xiaoyu WANG,Bing LI,Guohui LIU. Research progress in application of inflammatory markers in diagnosis and treatment of coronary heart disease [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1173-1181.
[3]	Tong SHEN,Yang WANG,Wei JIN,Zhihui LIN,Li YAN. Risk factors analysis and risk model construction of cognitive frailty in elderly patients with chronic diseases [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1304-1309.
[4]	Cong FU,Yang YANG,Mingtu XU,Zeying QIN,Jingyang LI. Analysis on related influencing factors of life quality of inpatients with coronary heart disease [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 478-486.
[5]	Yang YU,Yang YANG,Mingtu XU,Zeying QIN,Cong FU,Jingyang LI. Mediating effect of perceived social support between self-esteem and anxiety in patients with coronary heart disease [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 216-221.
[6]	XU Xiaoyan, SONG Zikai, ZHANG Yang, QIN Ling. Changes of serum NT-pro BNP and Lp(a) levels in patients with acute myocardial infarction after emergency PCI and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 132-137.
[7]	XING Xunjing, QIN Ling, TANG Minglong, YANG Shuo, XU Guoliang. Effectiveness and securities of ticagrelor and clopidogrel in antiplatelet therapy for coronary heart disease in old people: A Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(01): 123-129.
[8]	ZHANG Tao, ZHANG Guoming, YAN Fei, LIU Zheng, HUO Qiang. Values of evaluation of heart rate variability in major adverse cardiac events in patients with acute myocardial infarction after PCI [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 780-785.
[9]	ZHU Tao, ZHANG Guoming, YAN Fei, LIU Zheng, HUO Qiang. Comparison of diagnostic values between myocardial perfusion imaging and dual source CT coronary angiography in coronary artery stenosis in patients with diabetes complicated with coronary heart disease [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 425-430.
[10]	ZHENG Dongchun, ZHANG Tianrong, LIU Hongbo, CHEN Huaiji, WANG Qi, XU Feng, ZHANG Yuezhu, ZHOU Liting, YE Lin. Association between genetic variations in 9p21 region and coronary heart disease in Chinese Han population [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 142-146.
[11]	ZHU Hongling, GENG Wentao, XIE Jinfang, LI Xueyang, YIN Shuo, BI Chongcai. Evaluation on clinical effect of CAD/CAM restorations in repairing posterior tooth defects in elderly people [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 157-161.
[12]	ZHANG Yang, WANG Junfeng, CAOHongyan, QIN Ling, XU Guoliang. Effectiveness and safety of Dengzhanhuasu and Dansheng Injection in treatment of patients with angina pectoris of coronary heart disease:A Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 317-321.
[13]	WANG Xu, JI Mingxin, HAO Mingyue, JIA Lina, YANG Tongwei. Influence of methylprednisolone in respiratory mechanics parameters in elderly patients with general anesthesia and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 361-364.
[14]	LIU Yingli, YANG Libin, ZHANG Shushi, ZHANG Shuyan. Therapeutic effect of ButylphthalideInjection inelderly patients with acute cerebral infarction and its influence incerebral hemodynamics andcerebral vascular reserve [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 344-348.
[15]	JIANG Wenping, HOU Sen, LIN Qiuyu, GU Li, ZHAO Hongguang. Value of adenosine triphosphate stressand rest nuclide myocardial perfusion imaging in diagnosis of female patients with coronary heart disease [J]. Journal of Jilin University Medicine Edition, 2016, 42(02): 370-374.